
DNA vs GLUE
$DNA vs $GLUE head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DNA vs GLUE: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Neither kept up with the market over the past year: DNA +3.1% and GLUE -37.1%, against the S&P 500 at +8.8%.
- ·DNA is within 2.4% of resistance at $8.40, a price where it has stalled before.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
DNA vs GLUE: the quick read
- ·GLUE is the larger company by market cap ($775M vs $568M).
- ·DNA has been more active on our scanner (199 vs 109 alerts in 30 days).
- ·DNA has the smaller float (65.6M vs 70.7M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 199 and 109 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 36% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
Objective differences only. Not investment advice.
Watching DNA or GLUE? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DNA and GLUE on TheDesperateTrader.
- Is DNA or GLUE the better stock?
- "Better" depends on your goal, and these two are not alike. GLUE is the larger company by market cap ($775M vs $568M). DNA has been more active on our scanner (199 vs 109 alerts in 30 days). DNA has the smaller float (65.6M vs 70.7M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DNA and GLUE?
- The differences that matter: they are similar in size ($568M vs $775M); they trade at very different share prices ($8.20 vs $8.90); DNA sits at 22% of its 52-week range against 0% for GLUE; our scanner flagged DNA 199 times in the last 30 days against 109 for GLUE. Everything above is measured from the latest completed session and SEC filings.
- Which of DNA and GLUE is more active right now?
- Right now DNA is at about 0.7x its normal volume and GLUE is at about 0.9x, so GLUE is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is DNA or GLUE in the stronger trend?
- DNA is below its 50-day average of $10.41 and below its 200-day average of $8.63; GLUE is below its 50-day average of $10.89 and below its 200-day average of $16.51. DNA leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DNA or GLUE? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore DNA and GLUE comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.